An efficient synthesis of optically active metabolites of platelet adhesion inhibitor OPC-29030 by lipase-catalyzed enantioselective transesterification
被引:16
|
作者:
Kitano, K
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Kitano, K
[1
]
Matsubara, J
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Matsubara, J
[1
]
Ohtani, T
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Ohtani, T
[1
]
Otsubo, K
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Otsubo, K
[1
]
Kawano, Y
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Kawano, Y
[1
]
Morita, S
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Morita, S
[1
]
Uchida, M
论文数: 0引用数: 0
h-index: 0
机构:
Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, JapanOtsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
Uchida, M
[1
]
机构:
[1] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Tokushima 7710192, Japan
The optically active metabolites of (S)-3,4-dihydro-6-[3-(1-o-tolyl-2-imidazolyl)sulfinylpropoxy]-2(1H)-quinolinone (OPC-29030, 1), which is a new anti-platelet agent (platelet adhesion inhibitor), were effectively synthesized by the enzyme-catalyzed enantioselective transesterification of the racemic sulfinyl metabolites. The enzymes can recognize a stereogenic sulfur atom remote fi om the reaction site. (C) 1999 Elsevier Science Ltd. All rights reserved.